Search
Tandem Diabetes Care Inc
TNDMAdd to Watchlist
15.315USD
-1.065-6.50%
Market hours 09/24, 14:34（ET）
1.05BMarket Cap
LossP/E TTM
Tandem Diabetes Care Inc (TNDM) Stock Price Target & Forecast
Analyst Rating
Based on 22 analysts giving stock ratings to Tandem Diabetes Care Inc in the past month.
Buy
4 Strong Buy
8 Buy
10 Hold
0 Sell
0 Strong Sell
Target Price
29.158USD+66.62%
TNDM Analyst Recommendation Trends
In the current month, TNDM has received 8 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. TNDM average Analyst price target in the last month is 29.158.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
4
4
4
4
4
4
4
3
8
8
8
8
6
5
5
5
10
9
11
11
14
14
14
15
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
22
21
23
23
24
24
24
24
TNDM Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Dexcom Inc
DXCM
13
13
4
0
0
30
Stryker Corp
SYK
11
13
6
0
0
30
Medtronic PLC
MDT
9
10
11
0
0
30
Zimmer Biomet Holdings Inc
ZBH
2
6
21
0
0
29
Abbott Laboratories
ABT
11
12
6
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Insulet Corp
PODD
7
8
12
0
0
27
Guardant Health Inc
GH
12
13
2
0
0
27
Repligen Corp
RGEN
5
14
3
0
0
22
West Pharmaceutical Services Inc
WST
6
12
1
0
0
19
Financial Forecasting
Based on analysts' estimates, TNDM EPS is projected to reach -0.241 in FY2026Q3, following reported EPS of -0.307 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.08
-0.44
-0.32
-0.24
0.17
Actual
-0.01
-0.30
-0.31
--
--
Surprise
+89.48%
+32.89%
+4.07%
--
--
FAQs
What is Tandem Diabetes Care Inc's expected revenue for the next quarter?
Tandem Diabetes Care Inc's expected revenue is 266.12M.
What is Tandem Diabetes Care Inc's price target?
Analysts forecast that Tandem Diabetes Care Inc's price target is USD 29.16, with the highest forecast at USD 50.00 and the lowest forecast at USD 18.00.
How have Tandem Diabetes Care IncTNDM's recent earnings per share performed?
The market expectation was USD -0.31, while Tandem Diabetes Care IncTNDM's earnings per share (EPS) for the previous quarter was USD -0.30. EPS for the next quarter is expected at USD -0.24.
What is the analyst rating for Tandem Diabetes Care Inc?
Based on the ratings of Tandem Diabetes Care Inc's stock from 22 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.